These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
300 related items for PubMed ID: 18267255
21. Membrane permeabilization: a common mechanism in protein-misfolding diseases. Lashuel HA. Sci Aging Knowledge Environ; 2005 Sep 21; 2005(38):pe28. PubMed ID: 16186179 [Abstract] [Full Text] [Related]
22. Mitochondria as targets for chemotherapy. Gogvadze V, Orrenius S, Zhivotovsky B. Apoptosis; 2009 Apr 21; 14(4):624-40. PubMed ID: 19205885 [Abstract] [Full Text] [Related]
23. Urinary dysfunction in Parkinson's disease: a review. Blackett H, Walker R, Wood B. Parkinsonism Relat Disord; 2009 Feb 21; 15(2):81-7. PubMed ID: 18474447 [Abstract] [Full Text] [Related]
24. Controlling the mass action of alpha-synuclein in Parkinson's disease. Kim C, Lee SJ. J Neurochem; 2008 Oct 21; 107(2):303-16. PubMed ID: 18691382 [Abstract] [Full Text] [Related]
25. The second brain and Parkinson's disease. Lebouvier T, Chaumette T, Paillusson S, Duyckaerts C, Bruley des Varannes S, Neunlist M, Derkinderen P. Eur J Neurosci; 2009 Sep 21; 30(5):735-41. PubMed ID: 19712093 [Abstract] [Full Text] [Related]
29. Regulation of ceramide-induced neuronal death: cell metabolism meets neurodegeneration. Arboleda G, Morales LC, Benítez B, Arboleda H. Brain Res Rev; 2009 Mar 21; 59(2):333-46. PubMed ID: 18996148 [Abstract] [Full Text] [Related]
30. Review: Familial Parkinson's disease--genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease. Schiesling C, Kieper N, Seidel K, Krüger R. Neuropathol Appl Neurobiol; 2008 Jun 21; 34(3):255-71. PubMed ID: 18447897 [Abstract] [Full Text] [Related]
33. Beer and bread to brains and beyond: can yeast cells teach us about neurodegenerative disease? Gitler AD. Neurosignals; 2008 Jun 21; 16(1):52-62. PubMed ID: 18097160 [Abstract] [Full Text] [Related]
34. Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders. Neff F, Wei X, Nölker C, Bacher M, Du Y, Dodel R. Autoimmun Rev; 2008 Jun 21; 7(6):501-7. PubMed ID: 18558370 [Abstract] [Full Text] [Related]
35. Impact of glucocorticoids and chronic stress on progression of Parkinson's disease. Kibel A, Drenjancević-Perić I. Med Hypotheses; 2008 Dec 21; 71(6):952-6. PubMed ID: 18718724 [Abstract] [Full Text] [Related]
37. The olfactory vector hypothesis of neurodegenerative disease: is it viable? Doty RL. Ann Neurol; 2008 Jan 21; 63(1):7-15. PubMed ID: 18232016 [Abstract] [Full Text] [Related]
38. High doses of nicotinamide prevent oxidative mitochondrial dysfunction in a cellular model and improve motor deficit in a Drosophila model of Parkinson's disease. Jia H, Li X, Gao H, Feng Z, Li X, Zhao L, Jia X, Zhang H, Liu J. J Neurosci Res; 2008 Jul 21; 86(9):2083-90. PubMed ID: 18381761 [Abstract] [Full Text] [Related]